Abstract:Background Hepatocellular carcinoma (HCC) is the major type of primary liver cancer. Intrahepatic metastasis, such as portal vein tumor thrombosis (PVTT), strongly indicates poor prognosis of HCC. But now, there are limited understandings of the molecular features and mechanisms of those metastatic HCCs. Methods To characterize the molecular alterations of the metastatic HCCs, we implemented an integrative analysis of the copy number variations (CNVs), DNA methylations and transcriptomes of matched adjacent normal, primary tumor and PVTT samples from 19 HCC patients. Results CNV analysis identified a frequently amplified focal region chr11q13.3 and a novel deletion peak chr19q13.41 containing three miRNAs. The integrative analysis with RNA-seq data suggests that CNVs and differential promoter methylations regulate distinct oncogenic processes. Then, we used individualized differential analysis to identify the differentially expressed genes between matched primary tumor and PVTT of each patient. Results show that 5 out of 19 studied patients acquire evidential progressive alterations of gene expressions (more than 1000 differentially expressed genes were identified in each patient). While, another subset of eight patients have nearly identical gene expressions between the corresponding matched primary tumor and PVTT. Twenty genes were found to be recurrently and progressively differentially expressed in multiple patients. These genes are mainly associated with focal adhesion, xenobiotics metabolism by cytochrome P450 and amino acid metabolism. For several differentially expressed genes in metabolic pathways, their expressions are significantly associated with overall survivals and vascular invasions of HCC patients. The following transwell assay experiments validate that they can regulate invasive phenotypes of HCC cells. Conclusions The metastatic HCCs with PVTTs have significant molecular alterations comparing with adjacent normal tissues. The recurrent alteration patterns are similar to several previously published general HCC cohorts, but usually with higher severity. By an individualized differential analysis strategy, the progressively differentially expressed genes between the primary tumor and PVTT were identified for each patient. A few patients aquire evidential progressive alterations of gene expressions. And, experiments show that several recurrently differentially expressed genes can strongly regulate HCC cell invasions.

Analysing protein–protein interaction networks of human liver cancer cell lines with diverse metastasis potential

CancerNet: a Database for Decoding Multilevel Molecular Interactions Across Diverse Cancer Types

Deciphering the Protein Protein Interaction Network Regulating Hepatocellular Carcinoma Metastasis

Integrated proteogenomic analysis revealed the metabolic heterogeneity in noncancerous liver tissues of patients with hepatocellular carcinoma

Bioinformatics Analysis of Metastasis-Related Proteins in Hepatocellular Carcinoma

In-depth analysis of secretome and N-glycosecretome of human hepatocellular carcinoma metastatic cell lines shed light on metastasis correlated proteins.

Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis.

Identification of cancer-related gene network in hepatocellular carcinoma by combined bioinformatic approach and experimental validation.

Comprehensive Profiling of Metastasis-Related Proteins in Paired Hepatocellular Carcinoma Cells with Different Metastasis Potentials

Investigation on Glycosylation Patterns of Proteins from Human Liver Cancer Cell Lines Based on the Multiplexed Proteomics Technology

Integrative molecular analysis of metastatic hepatocellular carcinoma

Proteomic Analysis on Metastasis-Associated Proteins of Human Hepatocellular Carcinoma Tissues

Glycoproteomics investigation of human hepatocellular carcinoma cell lines

Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Pathways Associated with Clinical Outcome in Hepatocellular Carcinoma

Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis

Bioinformatics Analysis to Identify the Key Genes Affecting the Progression and Prognosis of Hepatocellular Carcinoma

Genetic Analysis of Liver Metastatic Cell Lines with Different Metastatic Potential.

Discovery of Biomarkers in Hepatocellular Carcinoma Metastasis Using Bioinformatic Analysis

N-glycoproteome Analysis of the Secretome of Human Metastatic Hepatocellular Carcinoma Cell Lines Combining Hydrazide Chemistry, HILIC Enrichment and Mass Spectrometry

Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma

FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma.